TTS Pharma is committed to setting the standard for safety, quality, and legal compliance in the CBD sector. In line with guidance from the UK’s Food Standards Agency (FSA), we submitted our Novel Food scientific dossier in December 2019. This application has since been validated under dossier RP521.

RP521 is our only Novel Food submission and represents one of the most detailed CBD safety dossiers currently under review in the UK. It supports the safe use of CBD in food supplements and forms the regulatory foundation for all of our compliant food grade products.

All of our CBD products are available on a private or white label basis. We provide tailored OEM solutions, including Trading Standards Assured Advice across labelling, packaging, and promotional materials. Our compliance team works closely with clients to ensure every product meets the latest regulatory standards.

If your brand is seeking a trusted, compliant UK supply chain with European provenance and a longterm, sustainable business model, we welcome your commercial enquiry.